Table 4.

Medical versus LVAD therapy in ambulatory non-inotrope dependent advanced heart failure. A comparison of Patient Profiles at enrollment and raw mortality with medical therapy (MedaMACS), LVAD therapy (INTERMACS), and the medical and LVAD therapy groups of the ROADMAP study.^14,15.

	MedaMACS N=161	INTERMACS N=1753	ROADMAP Medical Therapy N=103	ROADMAP LVAD Therapy N=97
Patient Profile
Profile 4	12%	80%	34%	65%
Profile 5	32%	13%	28%	22%
Profile 6	49%	4%	34%	10%
Profile 7	7%	3%	2%	0%
Outcome
Death at 1 year	17%	16%	22%	20%
Death at 2 year	24%	28%	30%	26%